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Autophagy is the major intracellular degradation pathway that regulates long-lived proteins and organelles turnover. This
process occurs at basal levels in all cells but it is rapidly upregulated in response to starvation and cellular stress. Although
beingrecentlyimplicatedinneurodegeneration,itremainsstillunclearwhetherautophagyhasadetrimentalorprotectiverole.In
this study, we investigated the dynamics of the autophagic process in retinal tissue that has undergone transient ischemia, an
experimental model that recapitulates features of ocular pathologies, including glaucoma, anterior ischemic optic neuropathy
and retinal vessels occlusion. Retinal ischemia, induced in adult rats by increasing the intraocular pressure, was characterized
by a reduction in the phosphatidylethanolamine-modiﬁed form of LC3 (LC3II) and by a signiﬁcant decrease in Beclin-1. The latter
event was associated with a proteolytic cleavage of Beclin-1, leading to the accumulation of a 50-kDa fragment. This event was
prevented byintravitreal treatment withthe non-competitiveN-methyl-D-aspartate antagonistMK801andcalpain inhibitors orby
calpain knockdown. Blockade of autophagy by pharmacological inhibition or Beclin-1 silencing in RGC-5 increased cell death,
suggesting a pro-survival role of the autophagic process in this neuronal cell type. Altogether, our results provide original
evidence for calpain-mediated cleavage of Beclin-1 and deregulation of basal autophagy in the rat retina that has undergone
ocular ischemia/reperfusion injury.
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Autophagy is an evolutionarily conserved process by which
eukaryotic cells regulate the turnover of long-lived proteins
and cytoplasmic organelles. Depending on mechanisms and
functions, three types of autophagy have been described in
mammalians: macroautophagy, microautophagy and chaper-
one-mediated autophagy.
1
Macroautophagy (hereafter referred to as autophagy) is the
most prevalent form and involves the formation of the
autophagosome. This is a double-membrane structure that,
following engulfment of cytoplasmic components such as
proteins, lipid and damaged organelles, docks and fuses with
the lysosomal compartment to form the autolysosome. Here,
the content of the autophagosome is degraded by the
lysosomal hydrolases and recycled for macromolecular
synthesis and ATP generation.
Autophagy occurs at low basal levels in virtually all cells
performing homeostatic function, and acts as a catabolic
adaptive process in response to different forms of stress,
including starvation, growth factor withdrawal, high bioener-
getic demands, hypoxia, endoplasmic reticulum stress or
accumulation of protein aggregates.
2
Besides its participation in neuronal homeostasis,
3 devel-
opment and remodeling,
4,5 autophagy has recently drawn
increasing attention for its role in neuronal cell death
associated with chronic neurodegenerative disorders and
acute neuronal injury.
6 Dysfunctions in the autophagic
process have been linked to Alzheimer’s disease (AD),
Parkinson’s disease (PD), Huntington’s disease, as well as
to brain hypoxia/ischemia or trauma.
7
Retinal ischemia is a common clinical condition represent-
ing the main cause of visual impairment and blindness.
8
Ischemic phenomena occur in a variety of ocular pathologies,
including anterior ischemic optic neuropathy, retinal and
choroidal vessel occlusion, diabetic retinopathy, traumatic
optic neuropathy and glaucoma.
8,9
Common hallmark for these conditions is the progressive
degeneration and the ﬁnal loss of the retinal ganglion cells
(RGCs) that through the optic nerve ﬁbers transmit the visual
information to the central areas of the visual pathway. Block of
blood ﬂow to the retina triggers a self-reinforcing detrimental
cascade involving neuronal depolarization, calcium overload,
oxidative stress and alteration of glutamate homeostasis.
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10,11 At cellular level, transient retinal ischemia results
in extensive neuronal cell death characterized by an early
phase of necrosis and a prolonged phase of apoptosis.
12
Aim of this study was to investigate the dynamics of the
autophagic process in the retina by using both an in vivo
model of ocular ischemia induced by the transient elevation of
the intraocular pressure (IOP) and RGCs exposed to serum
withdrawal. Our results showed that autophagy deregulation
occurs during retinal ischemia. This was associated with
Beclin-1 cleavage mediated by calpains and dependent on
NMDA receptor activation. Furthermore, Beclin-1 silencing
reduced RGC viability under starvation, thus suggesting a
pro-survival role for autophagy in this experimental context.
Results
Beclin-1 localizes mainly in the ganglion cell layer of the
intact retina. Beclin-1 is part of a class III phosphatidy-
linositol-3-kinase (PI3K) complex that participates in the early
steps of the autophagic vesicles formation, and it is essential
for the recruitment of other Atg proteins to the pre-
autophagosomal structure.
13
Beclin-1 distribution in the retina was investigated by
immunoﬂuorescence. In intact retinas, Beclin-1 immunoreac-
tivity was diffused throughout all retina layers, with a higher
expression in the inner segment and particularly in the
ganglion cell layer (GCL) as shown in Figure 1a. To identify
the type of cell expressing Beclin-1, double-labeling experi-
ments with RGC and Mu ¨ller cell markers were performed. In
the GCL, Beclin-1 immunoreactivity partially colocalized with
the cytosolic and dendritic compartments of TUJ1-labeled
RGCs and with the glial ﬁbrillary acidic protein (GFAP)-
positive Mu ¨ller cell processes and end-feet-surrounding
RGCs as shown in Figures 1b and c.
Beclin-I and LC3II levels decrease under retinal
ischemia–reperfusion. LC3I is a cytosolic protein whose
lipidated form, LC3II (phosphatidylethanolamine-modiﬁed
form of LC3), is stably associated to the autophagosomal
membrane and is therefore considered an autophagy-
speciﬁc marker.
14 To determine whether an ischemic insult
can modulate autophagy in the retina, we monitored the
expression of LC3 and Beclin-1 by western blot in rat retinas
that have undergone high IOP.
Compared with the contralateral, non-ischemic eye, LC3II
levels were signiﬁcantly reduced in the ischemic retina
between 0 and 1h of reperfusion (Figure 2a) and returned to
basallevelsafter24hofreperfusion;nosigniﬁcantchangesof
the LC3 cytosolic form (LC3I) were detected over the
analyzed time points (Figure 2a).
The LC3II reduction was associated with a signiﬁcant
decrease of Beclin-1 in the post-ischemic phase. Following
ischemia,Beclin-1expressionwasbelowtheconstitutivelevel
during the ﬁrst 24h of reperfusion, showing a more
pronounced and signiﬁcant decrease after 1h of reperfusion
(Figure 2b). In the retina subjected to ischemia, Beclin-1 was
Figure 1 Expression pattern of Beclin-1 in the retina. (a) Representative tissue section of adult rat retina stained with primary antibody for Beclin-1. Immunoﬂuorescence
experiments show the diffused expression of Beclin-1 (green) in all retina layers and the more intense immunoreactivity in the GCL (white arrowheads). Cell nuclei were
counterstained with DAPI. Scale bar¼50mm. (b) Immunolocalization of Beclin-1 in RGCs. Beclin-1 immunoreactivity (green) was present in the cytoplasmatic and dendritic
compartments of TUJ1-immunoreactive RGCs (red; white arrows). (c) Double ﬂuorescence immunolabeling of Beclin-1 (green)/GFAP (red) shows colocalization (yellow
signal; white arrows) in the Mu ¨ller cell processes surrounding RGCs. Scale bar¼20mm. INL, inner nuclear layer; ONL, outer nuclear layer
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Cell Death and Diseasereduced by 36% at 1h of reperfusion when compared with the
protein level in the non-ischemic retina (Figure 2b).
After 7 days from the ischemic insult, the ischemic retinas
showed Beclin-1 and LC3II levels comparable to the basal
levels of non-ischemic retinas (Figure 2c).
Beclin-1 undergoes proteolytic cleavage following
retinal ischemia–reperfusion. In retinas that have
undergone high IOP, Beclin-1 reduction was accompanied
by the appearance of an additional band reactive to the anti-
Beclin-1 antibody and characterized by a molecular weight of
50kDa (Figure 2d). This fragment accumulated during the
ﬁrst hour of reperfusion and then slowly decreased over the
24h (Figure 2d), paralleling Beclin-1 reduction and thus
suggesting that cleavage of the full-length protein had
occurred.
Retinal ischemia leads to calpain activation. Previous
work from our and other groups showed the contribution of
excitotoxicity to neurodegeneration induced by ischemia in
the retina.
11,15 Overactivation of glutamate receptors, mainly
the NMDA subtypes, results in calcium overload and
consequent activation of calcium-dependent enzymes.
16
Together with the caspase cascade, also activation of the
calcium-dependent cysteine proteases, calpains, occurs in
excitotoxicity and represents an early step in the sequence of
events leading to neuronal death.
To investigate activation of calpains in our model, we
monitored the formation of a-spectrin breakdown products
(SBDPs) bywesternblot.Incontrasttocaspase-3,generating
a 150-kDa and an apoptotic-speciﬁc 120-kDa fragment,
calpains cleave non-erythroid a-spectrin into two breakdown
products of 150 and 145kDa.
17
The appearance of the typical 150/145-kDa doublet was
observed after 50min of ischemia (reperfusion time 0),
indicating a signiﬁcant calpain activation (Figures 3a and b).
Calpain activation further increased during the ﬁrst hour of
reperfusion and was maintained at 6 and 24h of reperfusion
(Figures 3aandb),showing a temporalproﬁleoverlapping the
appearance of the Beclin-1 fragment (Figure 2d). No
signiﬁcant modulation of the caspase-3-mediated 120-kDa
SBDP was detected at the same time points (Figures 3a and b).
At 24h after ischemia, an additional fragment of 105kDa was
detectable in all samples, suggesting a further proteolytic
cleavage of the substrate (Figure 3a).
Beclin-1 cleavage is dependent on calpain activity and
NMDA receptor activation. To identify the temporal
Figure 2 Time-dependent changes of LC3 and Beclin-1 following retinal ischemia are paralleled by Beclin-1 proteolytic cleavage. Rats were subjected to retinal ischemia
in the right eye (R) for 50min and killed at the indicated time point (Rep, reperfusion time). For each animal, left eye (L) was used as control. Total proteins were analyzed by
western blotting for LC3 (a and c) or Beclin-1 (b–d), and equal loading was conﬁrmed by immunoblotting with anti-GAPDH antibody. Histograms show the result of the
densitometric analysis after normalization using the internal loading control. (a) In the ischemic retina (R), LC3II levels were signiﬁcantly decreased at the end of the ischemia
(Rep 0) and maintainedbelow basal levels during the ﬁrst hour of reperfusion. (b) Ischemia-induced Beclin-1 reduction with a peak at 1h of reperfusion as compared with the
leftnon-ischemicretina.(c)LC3andBeclin-1expressionafter7daysofreperfusion.(d)Representativeimmunoblotshowingtheappearanceandaccumulationofthe50-kDa
proteolytic fragment of Beclin-1 during the post-ischemic phase. Note that fragment was detectable only by longer exposure time compared with the full-length protein. Bars
represent mean±S.E.M. from ﬁve to six rats in each group. *Po0.05, ***Po0.001 versus L. L, left retina; MW, molecular weight; R, right ischemic retina
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Cell Death and Diseasesequence of events leading to Beclin-1 cleavage, we ﬁrst
investigated the consequences of an NMDA receptor block
on calpain activation and Beclin-1 modulation.
Intravitreal administration of the use-dependent, non-
competitive NMDA receptor antagonist MK801 (50nmol,
given 5min before ischemia and at the beginning of the
reperfusion) abolished calpain activation, as shown by the
reduction of the 150/145-kDa fragments (Figure 3c). The
same treatment also reduced the accumulation of the 50-kDa
Beclin-1 fragment at 1h of reperfusion (Figure 3d).
To further correlate Beclin-1 cleavage to activation of
calpains, the effect of the two calpain inhibitors MDL28170
(calpain inhibitor III) and SJA6017 was studied.
As expected, intravitreal injection of the calpain inhibitors
(1mM, 3ml/eye, given intravitreally 5min before ischemia
induction and at the beginning of reperfusion) blocked calpain
activity at 1h of reperfusion, as shown by the absence of the
typical 150/145-kDa fragments (Figure 4). Pharmacological
inhibition of calpains was paralleled by a signiﬁcant reduction
in the formation of the Beclin-1 fragment and by the increase
of the full-length protein at 1h of reperfusion (Figure 4).
Finally, knockdown of both m- and m-calpain isoforms was
performed by using a calpain small-subunit 1 small interfering
RNA (CAPNS1 siRNA).
Effectiveness of silencing was checked by monitoring the
appearance of the 150/145-kDa calpain-mediated SBDP in
retinas subjected to ischemia and reperfused for 1h
(Figure 5a). A substantial reduction in a-spectrin proteolysis
was detected in the retinas of rats receiving the intravitreal
injection of siRNA (10mg/eye, 48h before ischemia) when
compared with the vehicle and the non-targeting scramble
siRNA-treated animals (Figure 5a).
Silencing of CAPNS1 completely prevented the appear-
anceofthe50-kDa Beclin-1fragmenttypicallyobservedinthe
ischemic retinas after 1h of reperfusion (Figure 5b), thus
conﬁrming that, in our experimental setting, calpains were
responsible for Beclin-1 cleavage.
Autophagy promotes RGC-5 survival. Depending on the
context, autophagy has been shown to have either pro-
survival or pro-death functions. To test the role of autophagy
on RGCs survival, we induced autophagy in RGC-5 cells by
serum starvation
18 and assayed cell viability.
Cells starved for 24h showed a signiﬁcant increase of
Beclin-1 and LC3II levels (Figure 6a) and an altered
intracellular localization of LC3, as revealed by immunoﬂuor-
escence (Figure 6b). Cells grown in nutrient-rich medium
(10% serum; CTR) showed a diffused LC3 cytoplasmic
distribution, whereas cells that have undergone serum
deprivation (SD) showed intense dot-like LC3-positive struc-
tures, indicating the localization of LC3II on autophagic
membranes and the increase of autophagosome formation
(Figure 6b).
Serum starvation signiﬁcantly reduced RGC-5 cell viability
(Figure 6c). To determine the effects of autophagy inhibition
on cell survival, cells were treated with two autophagy
Figure 3 Blockade of NMDA-R by MK801 prevents calpain activation and Beclin-1 cleavage following retinal ischemia. (a) Immunoblotting showing the increase of
calpain-speciﬁc150/145-kDaSBPDsintheischemicretina(R)after50minofischemia(Rep¼0)and1,6or24hofreperfusion.Notethelackofaccumulationofthe120-kDa
caspase-3 product. Histograms in (b) show the results of the densitometric analysis of the autoradiographic bands relative to 150/145- and 120-kDa SBDP normalized to the
valueoftubulinand comparedwith theleft eye (L).(c) MK801reducedthecalpainactivationinducedby retinaischemia/reperfusionat theendof theischemia(leftpanel)and
after1hofreperfusion(rightpanel),asshownbythereducedintensityofthe150/145-kDaSBDP.Arepresentativeimmunoblotfromthreeindependentexperimentsisshown.
(d) Effect of MK801 treatment on Beclin-1 cleavage. Treatment with the NMDAantagonist signiﬁcantly prevented the accumulationof the 50-kDa Beclin-1 fragment observed
at 1h of reperfusion. Histograms show the results of the densitometric analysis of Beclin-1 fragment immunoreactive band normalized to the value of loading control. Each
value is the mean±S.E.M. of three experiments. In histogram b,* Po0.05 versus L; ***Po0.001 versus L; and
#Po0.05 versus vehicle. MW, molecular weight; R, right
ischemic eye; Rep, reperfusion time
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Cell Death and Diseaseinhibitors: baﬁlomycin A1 (BafA1), which increases intravesi-
cular pH and therefore inhibits autophagy completion,
19 and
3-methyladenine (3-MA), a nucleotide derivative that blocks
class III PI3K activity
20 upstream of LC3II formation.
TreatmentofRGC-5withBafA1(100nM
18)for24hstrongly
increased the accumulation of the lipidated form of LC3 and
signiﬁcantly reduced cell viability under starvation (46 versus
69% of serum-starved cells; Po0.05; Figures 6d and e). A
similareffectoncellsurvivalwasobtainedwhenthecellswere
exposed to 3-MA (10mM
18) during the 24h of SD (16 versus
69% of serum-starved cells; Po0.05; Figure 6e).
Beclin-1 silencing reduces RGC-5 viability under
starvation. To investigate the effects of Beclin-1 reduction
on RGC survival, cells were transfected with rat Beclin-1-
siRNA 48h before SD. Gene silencing reduced Beclin-1
expression by 95% compared with starved scramble-
transfected cells as shown by western blotting analysis
(Figure 7a) and led to a reduction of LC3II formation under
starvation (Figure 7a) similar to the pattern observed in vivo
(Figure 2). Beclin-1 silencing signiﬁcantly worsened the
reduction of RGC-5 viability, as assessed by 3-(4,5-
dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide
(MTT) assay, after 24h of starvation (36 versus 67% of
serum-starved cells; Po0.05; Figure 7b).
Discussion
Depending on the circumstances, autophagy can have both
beneﬁcial and detrimental effects on neurons. Blocking of
Figure 4 Beclin-1 cleavage depends on calpain activation. Representative western blotting showing the effect of calpain inhibitors MDL28179 and SJA6017 on calpain
activation and Beclin-1 cleavage at 1h of reperfusion. Calpain inhibition by intravitreal treatment with MDL28170 or SJA6017 completely prevented the accumulation of the
150/145-kDa SBDP, and signiﬁcantly reduced Beclin-1 cleavage as shown by the reduction of the 50-kDa band corresponding to Beclin-1 fragment and the recovery of the
60-kDa full-length protein band. Control animals were subjected to intravitreal injection of the vehicle corresponding to the treatment (DMSO 10%). Densitometric analyses of
the autoradiographic bands, normalized to the value of the loading control, are reported in the histograms. Values are the mean±S.E.M. of three independent experiments.
*Po0.05, **Po0.01 versus vehicle. L, left eye; MW, molecular weight; R, right ischemic eye
Figure 5 Beclin-1 proteolytic cleavage is abrogated by calpain knockdown. (a) Effectiveness of calpain small-subunit (CAPNS1) silencing. In vivo knockdown of calpains
by intravitreal injection of a speciﬁc CAPNS-siRNA was veriﬁed by the abrogation of the calpain proteolytic activity on a-spectrin in animals subjected to 50min of ischemia,
followed by 1h of reperfusion. Western blotting analysis showed no changes of calpain proteolytic activity in the retinas from animals treated with the scramble non-targeting
(NT) siRNA. Densitometric analysis of the 150/145-kDa SBDP bands showed a reduction by 87% in the CAPNS1 siRNA-treated animals (CAPNS1-siRNA¼0.13±0.11
versus vehicle¼1±0.02). (b) Beclin-1 cleavage was completely abrogated in the CAPNS1-silenced retinas subjected to ischemia, as shown by the absence of the 50-kDa
proteolyticfragmentandtherecoveryofthefull-lengthproteinobservedat1hofreperfusion.Histogramsshowthedensitometricanalysisoftheautoradiographicbands.Each
value is the mean±S.E.M. of three independent experiments. ***Po0.001 versus vehicle and NT siRNA. L, left eye; MW, molecular weight; R, right ischemic eye
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Cell Death and Diseaseautophagy causes neurodegeneration,
3,4 and alterations of
the autophagy pathway have been observed in chronic
neurodegenerative conditions, including AD,
21 PD
22 and
Huntington’s disease.
23 Autophagy is also activated in
neuronal cells exposed to hypoxic,
24 excitotoxic
25 or ischemic
injuries.
26
Retinal ischemia is a common clinical condition and a
relevant cause of visual impairment and blindness. Ocular
ischemia induced by transient elevation of IOP in rat is a
common animal model used to investigate the mechanisms
underlying retinal neuronal death. With this method, a global
ischemia is produced by the obstruction of both retinal and
uveal circulation, leading to pathological features similar to
those observed after central retinal artery occlusion and acute
angle-closure glaucoma.
8 We investigated the participation of
autophagy in the neurodegenerative processes accompany-
ing ischemia in the retina following IOP and observed a
decrease in LC3II, the autophagosomal associated form of
LC3. This was accompanied by Beclin-1 reduction during the
reperfusion phase and was indicative of a general deregula-
tion of the retinal autophagic machinery following ischemia/
reperfusion. Although Beclin-1 appeared to be expressed
throughout all retinal layers, higher immunoreactivity was
detected in the RGCs, suggesting a prevalence of the
autophagic process in this neuronal type.
In our model, Beclin-1 reduction was associated with the
appearance of a 50-kDa fragment in the ischemic retinas
during the ﬁrst hour of reperfusion, suggesting the occurrence
of a proteolytic cleavage. Caspases 3, 7 and 8 have recently
been reported to cleave Beclin-1, producing two proteolytic
fragments of 35 and/or 37kDa.
27,28 However, the late time of
caspase activation following ischemia in the retina (12h after
reperfusion
29), as well as the different molecular weights of
the fragments seemed to exclude the involvement of this
cascade in this cleavage. Therefore, we investigated the role
of the major alternative degradation pathway of calpains,
whose activation has been reported after ocular hypertension
in rat
30 as well as in primate retinas during hypoxia.
31 Calpain
inhibition by MDL28170 and SJA6017, as well as calpains
silencing by siRNA prevented the formation of the fragment,
thus indicating the contribution of these enzymes to Beclin-1
cleavageinourmodel.Calpain-mediatedcleavageofBeclin-1
was previously reported in recombinant assay in vitro
32 and in
cultured hepatocytes exposed to anoxia/reoxygenation.
18,33
However, to the best of our knowledge, our data represent the
ﬁrst evidence of Beclin-1 cleavage in neuronal tissue and the
ﬁrst report of Beclin-1 as a substrate of calpains in vivo.
Calpains are calcium-dependent enzymes activated by
intracellular Ca
2þ increase consequent to glutamate recep-
tors overactivation and associated with excitotoxicity.
16
Figure 6 SD induces autophagy in RGC-5 cells. (a) Effect of SD on Beclin-1 and LC3 expression. Representative western blot showing the expression of Beclin-1 and
LC3I and II in RGC-5 cell control (10% FBS; CTR) and starved (0% FBS; SD) for 24h. Histograms show densitometric analysis. Data were normalized for GAPDH and
expressed as percentage of control values, n¼5, *Po0.05. (b) Immunocytochemistry for LC3 in RGC-5 cells in presence (control) or absence of serum (serum deprived).
After 24h of SD, LC3 immunoreactivityshows a punctuate patterndue to the localization of LC3II in the autophagosome membrane. (c) SD reduces RGC-5 cell survival. Cell
viability was measured by MTT assay (CTR¼100±1.5; S.D.¼54±1.5; n¼5). (d) Effect of BafA1 treatment on LC3 expression. Western blot, representative of three
independentexperiments,showstheaccumulationofLC3IandIIinRGC-5treatedwithBafA1inpresenceorabsenceofserumfor24h.(e)Effectoftreatmentwithautophagy
inhibitorson cellsurvivalof starvedRGC-5.RGC-5 cellsweretreatedwith BafA1(100nM)and3-MA (10mM)for24h underSDandviability evaluatedby MTTassay(n¼3).
Each bar represents the mean±S.E.M. *Po0.05
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Cell Death and DiseaseThe latter contributes to a variety of acute and chronic
neurodegenerative diseases and has a key role also in RGC
death associated with retinal ischemia.
10 However, the
relation between autophagy and excitotoxic cell death is still
controversial. NMDA treatment of organotypic hippocampal
slices, as well as striatal injection of kainic acid, is associated
with induction of autophagy. In these same models, inhibition
of autophagosomal formation prevented neuronal death,
25,34
linking excitotoxicity to induction of autophagy via a common
Ca
2þ-mediatedpathway.Incontrast,recentstudiesidentiﬁed
inhibitors of intracellular Ca
2þ currents as activators of
autophagy.
35,36 In agreement with the latter observation, our
data would support a Ca
2þ-mediated inhibition of autophagy
via the calpain-mediated Beclin-1 cleavage and provide a
possible link between excitotoxicity and the impaired autop-
hagy often observed in neurodegenerative diseases.
NMDA receptor antagonists and calpain inhibitors have
been shown to reduce neurodegeneration triggered by
ischemia in the retina.
11,30 Thus, the calpain inhibitor
SJA6017 reduced cell loss in the GCL after retinal ische-
mia–reperfusion;
30 furthermore, neuroprotection by calpain
inhibition has been also reported in an acute ocular hyperten-
sion/ischemia model
37 and following NMDA-induced retinal
damage.
38 Our data suggest that prevention of Beclin-1
cleavage and autophagy deregulation might be implicated in
the neuroprotection afforded by NMDA receptor antagonists
and calpain inhibitors in retinal ischemia–reperfusion injury.
To date, very little is known on the role of the autophagic
pathwayinRGCdeath.Activationofautophagywasobserved
in RGC following optic nerve transection, and a protective role
was suggested for this process in RGC-5 cells under
starvation.
18 A persistent accumulation of autophagosomes,
concurring to the injury-induced axonal degradation and
secondary to the lesion-induced calcium inﬂux, was reported
in the optic nerve following optic nerve crush.
39
In our study, Beclin-1 knockdown in starved RGC-5
prevented LC3II formation, thereby the induction of autop-
hagy, and increased the cell death rate. This result, in
accordance with previous work,
18 points toward a neuropro-
tective role of autophagy in RGC exposed to detrimental
stimuli.
Insummary,ourﬁndingsprovideevidenceoftheautophagy
impairment in the ischemic retina, support a neuroprotective
role of autophagy in RGCs and suggest that excitotoxicity
negatively regulates autophagy through the calpain-mediated
cleavage of Beclin-1.
In recent years, the connection between autophagy and
neurodegeneration has been strengthened by several studies
highlighting the vulnerability of neurons to stress-related
signals that impair the autophagic process. Our study
suggests that alterations of the autophagic pathway might
be an important aspect in retinal pathologies associated with
ischemic events and, therefore, a potential target for new and
supporting therapeutic interventions.
Materials and Methods
Retinal ischemia injury. Male Wistar rats (280–330g) were purchased from
Charles River (Lecco, Italy). Animals were housed with a 12-h light–dark cycle with
ad libitum access to food and water. Animal care and experiments were carried out
in accordance with the guidelines of the Italian Ministry of Health for Animal care
(DM 116/1992).
Retinal ischemia was induced in adult rats by acutely increasing the IOP
according to the method previously reported.
15
Figure 7 Beclin-1 silencing reduces RGC-5 viability following SD.
(a) Effectiveness of Beclin-1 silencing and effect on LC3. Transfection of speciﬁc
Beclin-1-siRNA or scramble non-targeting (NT) sequence at ﬁnal concentration of
25nM was performed, 48h before SD, in 96-well plate with Lipofectamine 2000
according to the manufacturer’s instructions. In Beclin-1-siRNA-transfected cells,
expression of the protein was reduced by 95% and was paralleled by LC3II
reduction. Histograms show the densitometric analysis of autoradiographic bands.
Data were normalized for GAPDH and expressed as percentage of control values
(n¼3). (b) Effect of Beclin-1 knockdown on survival of serum-deprived RGC-5
cells. Each bar represents the mean±S.E.M. (n¼3) of cell viability, as assessed
by the MTT assay. *Po0.05 versus NT siRNA and SD (SD, 0% FBS).
MW, molecular weight
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Cell Death and DiseaseAnimals were deeplyanesthetizedby intraperitoneal injection of urethane (1.5g/kg)
and laid on a heating pad to maintain the body temperature at 371C. Topical
anesthesia was induced by 0.4% oxibuprocain eye drops (Novesina, Novartis,
Varese, Italy). A 27-gauge infusion needle, connected to a 500-ml bottle of sterile
saline,wasinsertedintheanteriorchamberoftherighteye,andthesalinecontainer
was elevated to produce an IOP of 120mmHg for 50min. Retinal ischemia was
conﬁrmed by whitening of the fundus. For each animal, the left eye was used as
non-ischemic control.
Body temperature was monitored before and after ischemia, and animals with a
value lower than 35.51C were excluded. Animals were killed by cervical dislocation
at the end of the ischemia or at 1, 6, 24h or 7 days after ischemia. Eyes were
removed, retinas quickly dissected, snap frozen in liquid nitrogen and stored at
 801C until use. Time points were chosen based on our previous study.
15
Cell culture and treatments. The rat RGC line (RGC-5), established by
transforming rat postnatal day 1 retinal cells with the 2C E1A virus,
40 was
purchased from the American Type Culture Collection (Manassas, VA, USA). Cells
wereculturedinhigh-glucoseDulbecco’sModiﬁedEagle’sMediumwith L-glutamine
(Invitrogen, Carlsbad, CA, USA), supplemented with 10% fetal bovine serum (FBS;
Invitrogen) and were grown at 371C in a humidiﬁed atmosphere with 5% CO2.
Depending on the experiment performed, cells were seeded in 6- or 96-well plates,
in 10cm petri dishes or coverslip and grown for 24h before treatments.
Cellsweresubjectedtostarvationinserum-freemediafor24h.Whereindicated,
Baﬁlomycin A1 (BafA1; 100nM; Sigma-Aldrich, Milan, Italy) or 3-MA (10mM;
Sigma-Aldrich) were added to the medium and maintained during the starvation
period. Control cells were treated with the corresponding amount of vehicles.
Intravitreal administrations. The NMDA antagonist MK801 (Sigma-
Aldrich) was dissolved in sterile phosphate-buffered saline (PBS) A stock solution
of the calpain inhibitors MDL28170 or SJA6017 (Calbiochem, La Jolla, CA, USA)
was prepared in 100% dimethylsulfoxide (DMSO) at the concentration of 10 and
20mM,respectively.Thestocksweresubsequentlydilutedtotheﬁnalconcentration
using sterile PBS.
Intravitreal injection was performed by puncturing the eye with a 23-gauge
needle at the cornea–sclera junction and the drugs administered with a 5-ml
Hamilton syringe (Bonaduz, GR, Switzerland). MK801 (50nmol/5ml/eye),
15
MDL28170 (0.5–1.0mM/3ml/eye), SJA6017 (0.5–1.0mM/3ml/eye) or control
solution (2.5–5% DMSO in PBS/3ml/eye) was administered 5min before and at
the end of the ischemia. The duration of the injection was 3min in all instances. At
theindicatedtimepoints,animalswerekilled, andsubjectswith visiblelens damage
or vitreous hemorrhage were excluded from the study.
Knockdown of CAPNS1 and Beclin-1 expression by siRNA. An
siRNA speciﬁc for rat Beclin-1 (coiled-coil, myosin-like Bcl-2-interacting protein,
NM053739; ON-TARGET plus SMARTpool L-099237-01) or rat CAPNS1
(NM017118; ON-TARGET plus SMARTpool L-082111-01) was obtained from
DharmaconRNAiTechnologies(Chicago,IL,USA).ThesiRNAwasreconstitutedin
sterile RNase-free water at a ﬁnal concentration of 100mM. In all, 10mg of the
siRNA was delivered intravitreally 72h before inducing ischemia using a 10ml
Hamilton syringe. Scramble control siRNA (ON-TARGET plus Non-Targeting Pool
D-001819-10) was injected to exclude non-speciﬁc effect of the silencing.
For in vitro studies, RGC-5 was transfected, 24h before starvation, with speciﬁc
siRNA at a ﬁnal concentration of 25nM using Lipofectamine 2000 transfection
reagent (Invitrogen) according to the manufacturer’s instruction.
Immunoblot analysis. Retinas or RGC-5 cells were lysed in ice-cold RIPA
buffer (50mM Tris-HCl (pH 8), 150mM NaCl, 1mM EDTA, 0.1% SDS, 1% IGEPAL
and 0.5% sodium deoxicholate) containing protease (code P8349; Sigma-Aldrich)
and phosphatase inhibitor cocktails (code 524625; Calbiochem). Lysates were
centrifuged for 15min at 10000 g at 41C, and supernatants were assayed
for protein content by the Bio-Rad DC Protein Assay Kit (Bio-Rad laboratories,
Milan, Italy).
For western blot analysis,equal amount of total proteins was separated by SDS-
polyacrylamide gel electrophoresis (8% for a-spectrin; 12% for Beclin-1, Atg4, Atg7
and p62; and 15% for LC3) and transferred onto PVDF membranes (Immobilon-P,
Sigma-Aldrich). The membranes were blocked with 5% non-fat milk in Tris-buffered
saline containing 0.05% Tween 20 for 1h at room temperature (RT).
Primary antibodies were incubated overnight at 41C, followed by a horseradish
peroxidase-conjugated secondary antibody for 1h at RT. Protein bands were
visualized with the ECL Western Blotting Detection kit (ECL, Amersham
Biosciences, GE Healthcare, Milan, Italy), and the chemiluminescence signal
detected using X-ray ﬁlms (Hyperﬁlm ECL, Amersham Biosciences). Exposure time
to obtain the optimal density of the images varied from 5s to 20min.
Autoradiographic ﬁlms were scanned, digitalized at 300dpi and band quantiﬁcation
was performed using ImageJ software (NIH, Bethesda, MD, USA).
The following primary antibodies and dilutions were used: anti-Beclin-1 (code
PD017) 1:4000, anti-p62/SQSTM1 1:1000, anti-LC3 (code PD036) 1:2000 (MBL
InternationalCorporation,Nagoya,Japan);rabbitmonoclonalanti-Beclin-11:2000,
anti-Atg4 1:1000, anti-Atg7 1:1000 (Cell Signaling Technology, Beverly, MA,
USA); anti-spectrin (non-erythroid) monoclonal antibody (MAB 1622) 1:3000
(ChemiconInternationalInc.,Temecula,CA,USA);anti-actin1:1000(cloneAC-40,
Sigma-Aldrich); anti-b-tubulin 1:20000 (clone B-5-1-2, Sigma-Aldrich); and anti-
GAPDH 1:30000 (Applied Biosystems, Carlsbad, CA, USA). Species-speciﬁc
horseradish peroxidase-conjugated goat IgG (Pierce Biotechnology, Rockford, IL,
USA) were used as secondary antibodies.
Cell viability assay. Cell viability, evaluated as mitochondrial activity, was
quantiﬁed by measuring dehydrogenase activity retained in the cells by using the
MTT (Sigma-Aldrich) assay. The assay is based on the ability of living cells to
reduce MTT into insoluble formazan. Brieﬂy, cells (1500cell per well) were seeded
in 96-well plates and subjected to the appropriate treatment. After 24h, cells were
incubated with 0.5mg/ml MTT (100ml per well) for 2h in a humidiﬁed 5% CO2
incubator at 371C. Medium was then removed, and 100ml of DMSO (Carlo Erba,
Milan, Italy) was added to solubilize the formazan product. Absorbance was read at
540/690nm by using an ELISA reader (Labsystems Multiskan, Helsinki, Finland).
Data were expressed as cell survival percentage versus control cultures
(maintained in 10% FBS) set to 100%.
Immunohistochemistry and immunocytochemistry. Immediately
after the killing, eyes were enucleated and ﬁxed in 2% paraformaldehyde (PFA)
at 41C for 10min; the anterior segment was removed, the posterior was ﬁxed in 4%
PFA for 60min and cryopreserved in 30% sucrose overnight. Specimens were
frozen in Optimal Cutting Temperature compound (Tissue-Tek, Sakura Finetek
Europe, Alphen aan den Rijn, The Netherlands), and 10-mm cryostat sections were
cut, mounted onto Superfrost ultra plus glass slide (Menzel-Gla ¨ser, Braunschweig,
Germany) and stored at  801C until used.
Retinal sections were thawed, air dried and washed in 0.1-M PBS (pH 7.4).
Sections were permeabilized with 0.3% Triton for 30min and blocked with
10% donkey serum (Sigma-Aldrich) at RT for 1h. The slides were then incubated
with rabbit anti-Beclin-1 (1:50, MBL International Corporation) and mouse anti-
TUJ1 (bIII tubulin; 1:500; BabCo, Richmond, CA USA), to identify adult RGCs
(Cui et al., 2003; Huang et al., 2008), or with mouse anti-GFAP (1:800; MAB360;
Chemicon/Millipore, Billerica, MA, USA) to identify Mu ¨ller cells. Finally, sections
were incubated with anti-rabbit Alexa Fluor 488 (1:300) and/or anti-mouse Alexa
Fluor594(1:500; MolecularProbes,Eugene, OR, USA)at RT for 1h andmounted
with Vectashield mounting media with DAPI (Vector Laboratories, Burlingame,
CA, USA).
For immunocytochemistry, RGC-5 cells were plated on coverslips, ﬁxed with 4%
PFA for 20min at RT, permeabilized with Triton 0.3% for 5min and blocked with
10%donkey serum (Sigma-Aldrich) in PBS for 30min.LC3 protein was detectedby
incubating with anti-LC3 antibody (1:200; MBL International Corporation) in 5%
blockingbufferfor1hatRT,followedbyAlexaFluor488(1:500;MolecularProbes)
in 5% blocking buffer for 1h at RT. Coverslips were mounted with Vectashield
solution containing DAPI (Vector Laboratories).
Image acquisition was performed using a deconvolution microscope (Leica
EL6000 microsystem, Milan, Italy).
Statistical analysis. Data are given as mean±S.E.M. of three to six
independent experiments and statistically evaluated for difference by Student’s
t-test or by one-way analysis of variance, followed by Newman–Keuls or Tukey-
Kramer test for multiple comparisons. A value of Pr0.05 was considered
statistically signiﬁcant.
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